Fangda special steel: no transferee delisted at the expiration of the listing period of 60% equity transfer of jiangte automobile

Chassis Supply Chain's "iPhone Moment": China's Tier 1 Shift as LeeKr Emerges

Over the past decade, China's electric vehicle (EV) industry has evolved from a niche experiment into a leading force in the global automotive landscape. In the first ten months of 2025, China exported over 2 million EVs, nearly double the year-earlier figure. From European city streets to Southeast Asian highways and Latin American urban centers, Chinese EVs have emerged as one of the most prominent symbols of a new era of “Made in China.”

Unpacking China | Key Chinese Firms to Watch This Week （26/07/2026-01/08/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

Alphamab Licenses Cancer Drug to Pathos AI in Deal Worth More Than US$2.2 Billion

Alphamab Oncology (康宁杰瑞生物制药) has licensed the overseas rights to its experimental cancer drug JSKN016 to US-based Pathos AI in a deal potentially worth more than US$2.2 billion, marking another major overseas licensing agreement for China’s rapidly expanding innovative-drug sector.

Ningbo Ocean Shipping Launches First Europe-Bound Ro-Ro Service

On August 5, 2026, Ningbo Ocean Shipping Co., Ltd. (宁波远洋运输股份有限公司) launched its first roll-on/roll-off shipping service to Europe from Ningbo Zhoushan Port, marking the company’s entry into vehicle transportation and the first extension of its route network to the European continent.

Topchoice Medical: Is One Hospital Chain Propping Up this Rising Listed Company?

Behind the buoyant share prices of a unique healthcare offering in China.subsidiaries’ statements has contributed a large part.